Last reviewed · How we verify
Fundación Cardioinfantil Instituto de Cardiología — Portfolio Competitive Intelligence Brief
2 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Pharmaceutical fresh frozen plasma | Pharmaceutical fresh frozen plasma | marketed | ||||
| Ringer lactate (RL) | Ringer lactate (RL) | marketed | Crystalloid intravenous fluid | Critical Care / Fluid Resuscitation |
Therapeutic area mix
- Critical Care / Fluid Resuscitation · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Fayoum University Hospital · 1 shared drug class
- Federal University of Juiz de Fora · 1 shared drug class
- McGill University Health Centre/Research Institute of the McGill University Health Centre · 1 shared drug class
- Medical University of Vienna · 1 shared drug class
- Nationwide Children's Hospital · 1 shared drug class
- Rigshospitalet, Denmark · 1 shared drug class
- Scientific Institute San Raffaele · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Fundación Cardioinfantil Instituto de Cardiología:
- Fundación Cardioinfantil Instituto de Cardiología pipeline updates — RSS
- Fundación Cardioinfantil Instituto de Cardiología pipeline updates — Atom
- Fundación Cardioinfantil Instituto de Cardiología pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Fundación Cardioinfantil Instituto de Cardiología — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fundaci-n-cardioinfantil-instituto-de-cardiolog-a. Accessed 2026-05-18.